Skip to content
National Cancer Institute
U.S. National Institutes of Health
| www.cancer.gov
In English |
En español
Search
NCI Home
Cancer Topics
Clinical Trials
Cancer Statistics
Research & Funding
News
About NCI
Clinical Trials Search Results
Page Options
E-Mail This Search
Clinical Trial Questions?
Get Help:
1-800-4-CANCER
or
LiveHelp online chat
Quick Links
Help Using the NCI Clinical Trials Search Form
Educational Materials About Clinical Trials
About NCI's Cancer Clinical Trials Registry
Dictionary of Cancer Terms
NCI Drug Dictionary
View Content for:
Patients
Health Professionals
Display:
Title
Description with:
Locations
Eligibility
Full Trial Description
Custom
Results 1-8 of 8 for your search:
Drug:
liposomal cytarabine
Find trials that include:
Any drugs shown
Trial Status:
Closed
Hide Search Criteria
Show Search Criteria
Help with Results
Select All on Page
Sort by:
Phase of Trial
Title
Type of Trial
Status of Trial
Age Range
Sponsor of Trial
Protocol IDs
Show
10
25
50
100
200
Results per Page
1.
Phase IV Study of Liposomal Cytarabine (DepoFoam Encapsulated Cytarabine; DTC 101) for Neoplastic Meningitis in Patients with Solid Tumors, Including Primary Brain Tumors (Summary Last Modified 08/1999)
Phase:
Phase IV
Type:
Treatment
Status:
Closed
Age:
18 and over
Sponsor:
Pharmaceutical / Industry
Protocol IDs:
DTC-96-001
, NCI-V97-1337
2.
DepoCyt Therapy in Patients With Neoplastic Meningitis From Lymphoma or a Solid Tumor
Phase:
Phase IV
Type:
Treatment
Status:
Completed
Age:
18 and over
Sponsor:
Pharmaceutical / Industry
Protocol IDs:
SKY0101-010
, NCT00029523
3.
Treatment of Acute Lymphoblastic Leukemia or Aggressive Lymphoma With Relapse in Central Nervous System With Depocyt
Phase:
Phase III, Phase II
Type:
Treatment
Status:
Closed
Age:
18 and over
Sponsor:
Other
Protocol IDs:
GMALL06
, NCT00199108
4.
Phase III Randomized Study of DepoFoam-Encapsulated Cytarabine (DTC 101) vs Standard Intrathecal Therapy for Neoplastic Meningitis (Summary Last Modified 08/95)
Phase:
Phase III
Type:
Treatment
Status:
Closed
Age:
any age
Sponsor:
Pharmaceutical / Industry
Protocol IDs:
MSKCC-94129
, NCI-V95-0661
5.
Phase III Study of Liposomal Cytarabine Versus Standard Therapy for Neoplastic Meningitis in Patients With Leukemia, Lymphoma, or Solid Tumors (Summary Last Modified 09/1999)
Phase:
Phase III
Type:
Treatment
Status:
Closed
Age:
3 and over
Sponsor:
Pharmaceutical / Industry
Protocol IDs:
DTC-92-001
, NCI-V97-1338
6.
Phase II Study of Delayed Craniospinal Irradiation Following 6 Months of Intensive Chemotherapy, with a Phase I Study of an "Up-Front" Therapeutic Window with Thiotepa or Sustained Release Cytarabine in Children with Isolated CNS Leukemia
Phase:
Phase II
Type:
Treatment
Status:
Closed
Age:
6 mo. to under 21 at relapse
Sponsor:
NCI
Protocol IDs:
POG-9412
, NCT00002704
7.
DepoCyt for Active Lymphomatous or Leukemic Meningitis
Phase:
Phase II
Type:
Treatment
Status:
Closed
Age:
18 and over
Sponsor:
Other
Protocol IDs:
9010
, NCT00523939
8.
Phase I Dose Escalation Study of Liposomal Cytarabine (Depofoam Encapsulated Cytarabine; DTC 101) in Pediatric Patients with Recurrent or Refractory Meningeal Malignancies (Summary Last Modified 04/2002)
Phase:
Phase I
Type:
Treatment
Status:
Closed
Age:
1 to 21
Sponsor:
Pharmaceutical / Industry
Protocol IDs:
SKYEPHARMA-96-002
, DTC-96-002, NCI-V97-1336, NCT00003073
Select All on Page
Help with Results
NCI Home
|
Images Version
|
Contact Us
|
Policies
|
Accessibility
|
Viewing Files
|
FOIA
|
Site Help
|
Site Map
A Service of the National Cancer Institute